SyntheticGestalt Email Format
Biotechnology ResearchEngland, United Kingdom11-50 Employees
SyntheticGestalt operates in biotechnology research, developing machine learning models to support drug discovery and software that facilitates and automates life-sciences research workflows. The company focuses on molecular generative modeling and related tools to help researchers design and evaluate compounds more efficiently. A notable development is GENIAC Phase 3 milestones, which were presented to the industry at AI Leader's Meetup Spring in 2026. Based in London, England, SyntheticGestalt is a small to mid-sized team serving researchers in the life sciences sector seeking advanced computational approaches to accelerate discovery. Its activity and public appearances at major technology conferences reflect its position in the AI-enabled biotechnology space.